03.03.25|Corporate ServiceYaacov Michlin, CEO of BioLight and Chairman of the MIXiii Health-Tech.IL conference to be held on March 4-5, led by the Israel Advanced Technology Industries (IATI), reveals in a special interview how innovations in medical technologies are about to significantly ease the burden on patients with eye diseases
29.11.21|CTechAccording to the terms of the agreement, the company will retain the primary right to license technologies developed at Ichilov
27.09.18|Lilach BaumerThe company paid $7 million in 2017 for 19% of IOPtima, a developer of minimally invasive devices for eye surgery
21.11.17|Lilach BaumerThe Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange